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Abstract: Antagonists of mannose binding lectin (MBL)
have shown a protective role against brain reperfusion
damage after acute ischemic stroke. Here we describe the
design and streamlined synthesis of glycomimetic MBL an-
tagonists based on a new tetravalent dendron scaffold.
The dendron was developed by optimisation of a known
polyester structure previously demonstrated to be very ef-
ficient for ligand presentation to MBL. Replacement of
a labile succinyl ester bond with a more robust amide
functionality, use of a longer and more hydrophilic linker,
fast modular synthesis and orthogonal functionalisation at
the focal point are the main features of the new scaffold.
The glycoconjugate constructs become stable to silica gel
chromatography and to water solutions at physiological
pH, while preserving water solubility and activity in an
SPR assay against the murine MBL-C isoform. Higher-order
constructs were easily assembled, as demonstrated by the
synthesis of a 16-valent dendrimer, which leads to two
orders of magnitude increase in activity over the tetrava-
lent version against MBL-C.
Complex glycans on cell surfaces often function as recognition
signals for specific sugar-binding proteins known as lectins.
The C-type lectins are the largest lectin family found in animals
and are known to be involved in numerous physiological and
pathological processes, mostly in the immune system. Its
members are characterised by a carbohydrate recognition
domain (CRD) that requires a calcium ion to properly bind to
sugars. As most other lectins, C-lectins are oligomeric struc-
tures that compensate low affinity of individual CRDs with
avidity enhancements sustained by multiple interactions with
polyglycosylated targets. Many efforts have been devoted to
antagonising these interactions using multivalent glycosylated
constructs, varying from nanoparticles, to polymers, dendrim-
ers and other multivalent platforms.[1]
The serum mannose binding lectin (MBL) is a C-type lectin
that recognizes sugars in a Ca2+-dependent manner. Binding
of serum MBL to specific carbohydrate patterns[2] on the sur-
face of pathogens is an essential part of the innate immune re-
sponse.[3] MBL may also target “altered self” or damage-associ-
ated molecular patterns, such as dying or damaged cells[4] and
has been shown to have a crucial role in the pathophysiology
of brain ischemia/reperfusion injury.[5]
Over the past few years we have reported on two tetrava-
lent pseudo-mannosylated dendrons Polyman1 (1) and Poly-
man2 (2 ; Figure 1) that bind with good affinity to serum MBL[6]
as well as to a second immune system C-lectin, the dendritic
cell receptor DC-SIGN (dendritic cell-specific intercellular adhe-
sion molecule-3 grabbing non-integrin).[7] The two dendrons
are characterised by a common tetravalent polyester scaffold
built from 2,2-bishydroxymethyl-propionic acid units 3 and
bear four copies of either a pseudo-dimannoside (in 1) or
a pseudo-trimannoside (in 2) ligand (Figure 1).
Both pseudo-saccharides were designed and synthesised to
mimic the terminal moieties of the natural mannose glycan
(Man)9(GlcNAc)2, also known as Man9, that is a major binding
determinant of both lectins. In particular, 2 has found applica-
tion as antagonist of DC-SIGN-mediated viral infections[7,8] and
in the protection from brain reperfusion damage triggered by
MBL after acute ischemic stroke.[6]
Despite these promising results, 1 and 2 suffer from chemi-
cal instability that arise from the unhindered succinyl ester
bond (highlighted in red, Figure 1), which is labile to nucleo-
philes both under basic and mild acidic catalysis. This instabili-
ty prevents chromatographic analysis and purification on silica
(direct and reverse phase), hinders the scale up of the synthet-
ic process and hampers a full pharmacokinetic characterisation
of the molecules, all fundamental requirements for a potential
drug. Additionally, 30% hydrolytic degradation of 2 was mea-
sured (by NMR spectroscopy) after 6 h in water solution at
physiological pH (7.4, PBS buffer),[7] which is a clear drawback
for many in vivo applications. Not surprisingly, MS analysis of
hydrolysis mixtures revealed that the main decomposition oc-
curred by hydrolysis of the succinate bond, while the other,
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more hindered esters remained untouched. For all these rea-
sons, an optimisation of the dendron structure by replacement
of the succinyl ester bond was sought after.
Here we report on the synthesis of new tetravalent ana-
logues of 1 and 2, which have been stabilised against hydroly-
sis by appropriate modifications of the original scaffold. We
show that the new dendrons remain water soluble while dis-
playing improved stability and comparable activity as MBL an-
tagonists. Focal point functionalisation also allowed the easy
synthesis of higher order constructs with MBL affinity im-
proved by 2-orders of magnitude (valency corrected).
In order to achieve a significant stabilisation of 1 and 2
while introducing minimal changes to the original structure,
we sought to replace the labile succinyl ester linker at the den-
dron periphery with a more robust amide moiety (Figure 1).
This can be accomplished by connecting a 2,2-bis(aminome-
thyl)propionic acid building block (5) to the 2,2-bis(hydroxyme-
thyl)propionic ester focal unit 4 to obtain tetraamine 7
(Scheme 1). The synthesis of the stabilised dendron 9 can thus
be completed by reaction with a capping unit (8) derived from
diglycolic anhydride (6, Scheme 1). This 5-atom linker was pre-
ferred over succinate to minimize intramolecular cyclisation of
the amide group over the activated carboxylic acid during the
final functionalisation of 9. This side-reaction is well-known to
occur for aspartic acid derivatives that can form 5-member
ring imides upon activation.[9] Moreover, the linker derived
from 6 contains an ether bond that is expected to bestow
a more hydrophilic character to the final dendron. The ester
group at the dendron focal point can also be used to arm the
molecule with a terminal azide moiety, as in 4b, in order to in-
clude an anchoring point for further functionalisation and to
enable the synthesis of higher valency compounds.
The synthesis we have designed strives to minimize protec-
tion/deprotection steps[8] and involves the three building
blocks 4, 5 and 8. The focal unit 4 is obtained from 2,2-bis(hy-
droxymethyl)propionic acid 3 ; the benzyl ester 4a (R=Bn) is
also an intermediate in the synthesis of 5. The synthesis of the
building blocks is depicted in Scheme 2. The 2,2-bis(hydroxy-
methyl)propionic acid 3 was transformed in the corresponding
benzyl ester 4a using KOH and benzyl bromide (62% yield).
Similarly, 4b was obtained in 80% yield with Cs2CO3 and the
mesylate of 3-azidopropanol 10.[10] For the synthesis of 5, 4a
was treated with TsCl and pyridine to get 11 (94%), which was
subjected to a double nucleophilic substitution with sodium
azide affording intermediate 12 in 85% yields over the two
steps.
The Boc-protected amino acid 5 was finally obtained
through a one-pot catalytic hydrogenation of 12 in the pres-
ence of di-tert-butyl dicarbonate. This reaction sequentially af-
fords reduction of the azido groups to amines, protection of
the amines as Boc carbamates and removal of the benzyl ester
in 50% overall yield, after chromatographic purification.
Finally, the last building block 8 was synthesised by reaction
of diglycolic anhydride 6 with trimethylsilylethanol 13, fol-
lowed by EDC-mediated esterification of 14 with p-nitrophenol
15. The activated ester 8 can be used in the next step as
a crude (71% yield, determined by 1H NMR spectroscopy), al-
though flash chromatography purification was performed for
characterisation, affording pure 8 as a waxy white solid (56%
yield).
Figure 1. Tetravalent polyester dendrons Polyman1 (1) and Polyman2 (2) bearing, respectively, four copies of a pseudo-disaccharide and a pseudo-trisacchar-
ide. The labile succinyl ester bond is highlighted in the red box. The target of this work replaces the succinyl ester with an amide bond (blue box).
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The initial studies for the synthesis of the tetravalent con-
structs (Scheme 3) were performed using benzyl ester 4a as
the focal point unit. The tetravalent construct 16a was ob-
tained in 80% yield through a double condensation between
4a and two equivalents of 5 using DCC (dicyclohexylcarbodii-
mide) as the coupling agent (Scheme 3). Deprotection of 16a
(TFA, CH2Cl2) afforded tetraamine 7 that was not isolated but
treated with an excess of the activated ester 8, leading to the
protected tetravalent dendron 17a in 74% yield. Direct reac-
tion of 7 with diglycolic anhydride 6 was also attempted, but
abandoned for the difficulty of isolating and purifying the re-
sulting tetra-acid 18a from the reaction mixture. The corre-
sponding trimethylsilylethyl ester 17a, on the contrary, is
a very convenient precursor, which can be stored without deg-
radation for months and treated with TFA to deliver 18a when
needed. An analytical sample of 18a was purified by reverse
phase chromatography (Biotage SNAP C18, gradient elution:
from 100% H2O to 100% MeOH) but the acid was generally
used as a crude in the next synthetic step. Finally, the glyco-
dendrons 21a and 22a were synthesised in good yields (82
and 74%, respectively) by condensation of 18a and either the
pseudo-disaccharide 19[11] (HATU, DMA, 30 8C, 12 h) or the
pseudo-trisaccharide 20[7] (HATU/HOAT, DMA, 37 8C, 12 h). No-
tably, under these mild conditions, no nucleophilic attack of
the amide group over the activated carboxylic acid was ob-
served by MALDI analysis (HCCA, MeOH) of the crude reaction
mixtures. On the contrary, imide side-products were clearly de-
tected when the reaction was performed at 70 8C. A similar se-
quence starting from the azide-armed ester 4b afforded the
tetravalent ester 17b (Scheme 3), from which the tetravalent
glycodendron 21b was obtained in good yields (HATU, DMA,
35 8C, 12 h, 67%).
The resulting glycodendrons 21a-b and 22a were isolated
from their crude reaction mixtures by size-exclusion chroma-
tography (Sephadex LH-20) and, as opposed to 1 and 2, were
successfully purified by a further direct-phase flash chromatog-
Scheme 1. Retrosynthetic analysis of the stabilised tetravalent scaffold 9.
Scheme 2. Synthesis of the three building blocks 4a,b, 5 and 8.
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raphy on silica gel. Additionally, 21a and 21b were shown to
be stable to reverse phase HPLC purification conditions (H2O/
CH3CN in the presence of 0.1% of formic acid), and no hydroly-
sis of 22a was detected (1H NMR spectroscopy) in water solu-
tion at physiological pH (PBS buffer, pH 7.4) when monitoring
for up to four days. All glycodendrons were fully characterised
by NMR, ESI and MALDI (HCCA) mass spectroscopy.
Encouraged by the increased stability of the novel teatrava-
lent constructs, we employed the azide-armed dendron 21b
to generate a higher valency construct by Cu catalysed cyclo-
addition reaction with the tetravalent propargyl ether pentaeri-
tritol-derived core 23[12] (Scheme 4). This reaction proceeded
successfully affording in high yield (90%) the hexadecavalent
glycodendrimer 24, which could be isolated by size-exclusion
chromatography (Sephadex LH-20 column). An analytical
sample was further purified by reverse phase HPLC and fully
characterised by NMR and ESI mass spectroscopy.
In order to compare the activity of the new constructs with
that of Polyman2 (2), their inhibition potency against MBL was
assayed. MBL is found in mammalian sera as oligomers of trim-
ers[2] and is a paradigm of multivalent interactions. The lectin
normally has a protective role, as a complement activator in
the innate immune system and a scavenger of pathogens and
damaged cells. However, this role can be reversed in some
Scheme 3. Synthesis of dendrons 21a,b and 22a.
Scheme 4. Synthesis of the 16-valent dendrimer 24.
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acute inflammatory conditions, for example upon reperfusion
after an ischemic event. Animal model studies have indicated
that the MBL-mediated pathway increases the reperfusion
injury, possibly by recognising and attacking the damaged
tissue.[4] Indeed, MBL antagonists have been shown to reduce
the lesion extent.[4–6]
The inhibition potency of the new dendrons towards mouse
MBL-C (mMBL-C) was assessed by a recently established
assay[13] performed by surface plasmon resonance (SPR) directly
on murine plasma, which contains the two murine MBL iso-
forms A and C. In this assay the dendrons were incubated for
30 min at 25 8C at different concentrations in diluted mouse
plasma and the solutions were flowed onto a SPR sensor chip
on which mannosylated bovine serum albumin (Man-BSA) had
been previously immobilised. The amount of mMBL-C bound
to immobilised mannose residues was revealed flowing anti-
MBL-C antibody, the binding of which resulted in a clear SPR
signal (Supporting Information Figure S1). The preincubation
of plasma with the dendrons resulted in a concentration-de-
pendent decrease of the binding of the anti-MBL-C antibody
(Supporting Information Figure S1 and Figure 2&&ok?&& )
that is, a decrease of binding of mMBL-C to mannose residues.
From these inhibition curves IC50 values were determined
(Table 1). The data clearly show that the inhibitory activities of
the novel tetravalent constructs 21a and 22a are comparable
to that of the original lead 2 (Table 1). Almost two orders of
magnitude were gained with dendrimer 24, which corresponds
to a relative inhibitory potency (rIP) of 19, relative to 21a. The
activity of mannose was not measured in this test, but, for
comparison, the dissociation constant of the MBL–mannose
complex was estimated by various techniques to fall in the mil-
limolar range.[14]
In conclusion, we have succeeded in stabilising the structure
of tetravalent glycodendron antagonists of MBL, while preserv-
ing their biological activity against the target lectin. The novel
dendron design replaces a labile succinyl ester bond with
a more robust amide functionality, incorporating a longer and
more hydrophilic linker. As a result, the construct becomes
stable to silica gel chromatography and to water solutions at
physiological pH. The remaining ester linkages, bearing a qua-
ternary carbon in the a position, are clearly stabilised against
hydrolytic cleavage under physiological conditions. They may
also be partially stabilised against esterases,[15] a proposition
that we are now in the position to test experimentally. The
streamlined synthesis of the dendron and the possibility of or-
thogonal functionalisation at the focal point are very attractive
features of this system, as demonstrated by the easy synthesis
of the 16-valent construct 24. This dendrimer afforded activity
improvements against MBL-C by two-orders of magnitude rela-
tive to tetravalent 21. It is tempting to speculate that this
strong effect depends on the ability of 24 to bridge two bind-
ing sites in the MBL trimer, that are separated by 5 nm.[16] Per-
haps more importantly, this feature should allow the engineer-
ing of higher valency constructs with controlled ligand density
and spacing, which are important structural elements for pat-
tern-recognising receptors, such as MBL.[14] Finally, the stabi-
lised dendron scaffold 18, which is easily accessible in a few
steps of a highly modular synthesis, can find numerous addi-
tional applications as multivalent support of biologically active
payloads.
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Figure 2. Inhibition of mMBL-C binding to Man-BSA immobilised on a SPR
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then injected over a sensor chip where Man-BSA had been immobilised. The
amount of mMBL-C bound on the chip was revealed by flowing anti-MBL-C
antibodies. Dendrons inhibited in a concentration-dependent manner the
binding of mMBL-C to mannose residues. Each curve was obtained in 2 or 3
independent experiments; the points represent the mean SD (SD shown
for n=3).
Table 1. Inhibition of mMBL-C binding to Man-BSA immobilised on a SPR
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Scaffold Optimisation of Tetravalent
Antagonists of the Mannose Binding
Lectin
Novel dendrons for multipresentation :
Water soluble, tetravalent glycoden-
drons that perform as powerful man-
nose binding lectin (MBL) antagonists
are described. The stable scaffold adopt-
ed (see figure) is a versatile tool for
nested-layer multipresentation which
enabled the preparation of higher va-
lency antagonists&&ok?&&. All the
constructs were tested as MBL-C antag-
onist by an SPR assay and showed bind-
ing with IC50 values in the low micromo-
lar range.
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